– USA, MN – Minnetronix Medical, Inc., a leading medical technology company, today announced that its President, Jeremy Maniak, will succeed founder Richard Nazarian as CEO on February 1, 2020.
Maniak will report to and join the company’s board of directors with Nazarian continuing as its Chairman.
Nazarian founded Minnetronix in 1996 along with fellow 3M veterans Dirk Smith and Jon Pierce and the company has since grown to employ over 300 people and generate annual revenues of over $100M.
“I’m proud of what we’ve achieved over the past 23 years, but we’ve only scratched the surface of what this company is capable of,” said Nazarian. “Jeremy is just the right person at just the right time to build an enduring Minnetronix for years to come. I’m excited to see him take Minnetronix to even greater success.”
About Jeremy Maniak
Maniak has held several positions at Minnetronix since joining the firm in 2010 and will continue Minnetronix’ mission to positively impact the lives of patients through medical technology.
Maniak is a nine-year veteran of Minnetronix and was named COO in 2013. He is an experienced innovator and strategist with a background from Guidant and Leptos Medical. Maniak has helped advance Minnetronix’ product, technology and service solutions in support of consistent double-digit growth and a rapidly evolving neuro-interventional product portfolio.
“Minnetronix has come a long way since its founding and Rich has positioned us really well for growth and innovation long into the future. I am excited and honored to work with this exceptional Minnetronix team that is so dedicated to positively impacting our customers and patients,” said Maniak.
About Minnetronix Medical
Minnetronix Medical develops technology, service and product solutions for medical device companies and patients across the globe. The company focuses on four key vertical markets: patient-centered devices, fluidics, energy-based instruments and treatments, and optical systems.
For more information: https://minnetronixmedical.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.